Walgreens, Kroger Sue Pfizer For Delay Of Generic Lipitor

Law360, New York (July 6, 2012, 3:14 PM EDT) -- Walgreen Co., The Kroger Co. and three other retailers on Thursday lodged the latest suit to accuse Pfizer Inc. of using bogus patent applications and a conspiracy with Ranbaxy Inc. to delay generic versions of the blockbuster cholesterol treatment Lipitor.

Walgreens and Kroger — the nation's largest pharmacy and supermarket chains, respectively — said Pfizer and its subsidiaries used a wide range of anti-competitive tactics to extend their exclusive hold on the mega-grossing cholesterol drug by 20 months, at the expense of both retailers and consumers....
To view the full article, register now.